We are live on ! Find out more
GWPH

GW Pharmaceuticals Plc American Depositary Shares
GWPH

Delisted

GWPH was delisted on the 4th of May, 2021.

Back to rankings

87 hedge funds and large institutions have $548M invested in GW Pharmaceuticals Plc American Depositary Shares in 2014 Q4 according to their latest regulatory filings, with 29 funds opening new positions, 25 increasing their positions, 20 reducing their positions, and 26 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding in top 10

Funds holding in top 10: 1 → 2 (+1)

25% more repeat investments, than reductions

Existing positions increased: 25 | Existing positions reduced: 20

12% more first-time investments, than exits

New positions opened: 29 | Existing positions closed: 26

0% more funds holding

Funds holding: 87 → 87 (0)

14% less call options, than puts

Call options by funds: $15.9M | Put options by funds: $18.5M

16% less capital invested

Capital invested by funds: $650M → $548M (-$102M)

Holders
87
Holders Change
–
Holders Change %
0%
% of All Funds
2.32%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.05%
New
29
Increased
25
Reduced
20
Closed
26
Calls
$15.9M
Puts
$18.5M
Net Calls
-$2.55M
Net Calls Change
+$9.1M

Top Buyers

Rank Fund Capital Flow
1
Jennison Associates
Jennison Associates
New York
+$18.9M
2
Capital World Investors
Capital World Investors
California
+$15.3M
3
Fidelity Investments
Fidelity Investments
Massachusetts
+$11.1M
4
BFA
BlackRock Fund Advisors
California
+$10.2M
5
LCP
Lamond Capital Partners
California
+$9.8M

Top Sellers

Rank Fund Capital Flow
1
FCM
Farallon Capital Management
California
-$19.7M
2
O
OrbiMed
New York
-$17.9M
3
CCM
Cupps Capital Management
Illinois
-$8.1M
4
VAM
Visium Asset Management
New York
-$8.02M
5
CCP
Clough Capital Partners
Massachusetts
-$7.89M
Name Holding Trade Value Shares
Change 		Change in
Stake
Geode Capital Management
51
Geode Capital Management
Massachusetts
$209K +$37.3K +511 +20%
Deutsche Bank
52
Deutsche Bank
Germany
$185K +$128K +1,746 +175%
Bank of Montreal
53
Bank of Montreal
Ontario, Canada
$173K – – –
Creative Planning
54
Creative Planning
Kansas
$123K -$12.1K -165 -8%
SG Americas Securities
55
SG Americas Securities
New York
$104K +$112K +1,537 New
AIG
56
American International Group
New York
$66.1K -$11.4K -156 -14%
AIM
57
Advantage Investment Management
Iowa
$62K +$67.4K +923 New
Fifth Third Bancorp
58
Fifth Third Bancorp
Ohio
$61K +$29.2K +400 +80%
NPC
59
National Planning Corporation
California
$56.8K +$58.4K +800 New
MTIP
60
Magee Thomson Investment Partners
California
$55K – – –
OIA
61
Optimum Investment Advisors
Illinois
$37K +$40.2K +550 New
FANJ
62
Financial Architects (New Jersey)
New Jersey
$34K +$36.5K +500 New
Invesco
63
Invesco
Georgia
$23K +$2.19K +30 +10%
BKA
64
Brick & Kyle Associates
Pennsylvania
$20K +$21.9K +300 New
LTFS
65
Ladenburg Thalmann Financial Services
Florida
$14K -$18.8K -257 -55%
HNB
66
Huntington National Bank
Ohio
$14K +$15.3K +210 New
BRWM
67
B. Riley Wealth Management
Tennessee
$13K -$110K -1,500 -88%
FWM
68
Focused Wealth Management
New York
$11K – – –
NFG
69
Next Financial Group
Texas
$10K -$14.5K -198 -57%
BBPWM
70
Blue Bell Private Wealth Management
Pennsylvania
$10K -$7.3K -100 -40%
HIM
71
Hutchens Investment Management
New Hampshire
$10K +$11K +150 New
MFS
72
McNamara Financial Services
Massachusetts
$10K +$11K +150 New
FFC
73
First Financial Corp
Indiana
$9K – – –
MFS
74
MSI Financial Services
Massachusetts
$8K – – –
ASN
75
Advisory Services Network
Georgia
$8K +$7.3K +100 New
1 2
3
4 5

GWPH Hedge Fund Activity: Q4 2014 in Review

87 of the 3,750 institutional investors tracked by Wall St. Rank reported a position in GW Pharmaceuticals Plc American Depositary Shares (GWPH) for Q4 2014, worth a combined $548M — down 16% from $650M a quarter earlier.

Buyers outnumbered sellers: 29 funds opened new GWPH positions and 26 closed out — a net gain of 3 holders — while 25 added to existing stakes and 20 trimmed.

The largest buyer was Jennison Associates, opening a new position worth an estimated $18.9M. The largest seller was Farallon Capital Management, exiting entirely with an estimated $19.7M sold.

  • 87 institutional investors held GW Pharmaceuticals Plc American Depositary Shares (GWPH) as of Q4 2014, unchanged from Q3 2014.
  • Funds reported $548M of GW Pharmaceuticals Plc American Depositary Shares stock for Q4 2014, down 16% quarter-over-quarter.
  • 29 funds opened new GW Pharmaceuticals Plc American Depositary Shares positions in Q4 2014 and 26 closed out, a net change of +3 holders.
  • The largest GW Pharmaceuticals Plc American Depositary Shares buyer in Q4 2014 was Jennison Associates, an estimated $18.9M added.
  • The largest GW Pharmaceuticals Plc American Depositary Shares seller in Q4 2014 was Farallon Capital Management, an estimated $19.7M sold.

Based on aggregated 13F filings for Q4 2014.